ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Price Increase

July 22, 1983

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992

Without Advance Directives, Families Prolong Treatment

April 27, 2001

House Committee Expands Rauscher Pay Bill, Includes All NIH Directors, Asst. Secretary

July 30, 1976